Enfermedades infecciosas y microbiologia clinica · 2014
[Lopinavir/ritonavir in human immunodeficiency virus-infected women].
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Téllez María Jesús
Аннотация
There are clear sex-related biological differences between men and women. Diseases that affect the two sexes differently are studied separately. However, some diseases affect both men and women, but their incidence or outcome are clearly different. In human immunodeficiency virus infection, the potential differences in the effects of antiretroviral therapy are poorly characterized and few studies have been designed to elucidate these differences. Moreover, women are usually poorly represented in clinical trials of antiretroviral drugs.
Предметные рубрики MeSH
Anti-HIV AgentsBody SizeDrug CombinationsFemaleHIV InfectionsHIV Integrase InhibitorsHIV Protease InhibitorsHIV-Associated Lipodystrophy SyndromeHumansInfectious Disease Transmission, VerticalLopinavirMeta-Analysis as TopicMulticenter Studies as TopicPatient SelectionPregnancyPregnancy Complications, InfectiousRandomized Controlled Trials as TopicReverse Transcriptase InhibitorsRitonavirSex Characteristics